World's Best Scientists 2026 revealed!
Jeffrey A. Meyerhardt

Jeffrey A. Meyerhardt

D-Index & Metrics

Medicine

D-Index
125
Citations
60866
World Ranking
3086
National Ranking
1703

Overview

Jeffrey A. Meyerhardt is affiliated with Harvard University in the United States and has contributed extensively to the field of medicine, with a particular focus on oncology. Their research output spans over 668 publications in medicine, including 264 specifically in oncology.

Their work covers various subfields including:

  • Oncology
  • Physiology
  • Pathology and Forensic Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Key topics in their research involve:

  • Colorectal Cancer Treatments and Studies
  • Nutrition and Health in Aging
  • Colorectal Cancer Screening and Detection
  • Genetic factors in colorectal cancer
  • Nutritional Studies and Diet
  • Colorectal Cancer Surgical Treatments
  • Gastric Cancer Management and Outcomes

Meyerhardt's research has been published frequently in the following venues:

  • Journal of Clinical Oncology
  • Cancer Research
  • UNC Libraries
  • JNCI Journal of the National Cancer Institute
  • Gastroenterology

Recent significant papers authored or co-authored by Meyerhardt include:

  • Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology, 2021, Journal of the National Comprehensive Cancer Network
  • Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology, 2022, Journal of the National Comprehensive Cancer Network
  • American Cancer Society nutrition and physical activity guideline for cancer survivors, 2022, CA A Cancer Journal for Clinicians
  • Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline, 2022, Journal of Clinical Oncology
  • NCCN Guidelines Insights: Rectal Cancer, Version 6.2020, 2020, Journal of the National Comprehensive Cancer Network

The researcher collaborates frequently with the following co-authors:

  • Shuji Ogino
  • Andrew T. Chan
  • Charles S. Fuchs
  • Edward L. Giovannucci
  • Eileen M. O'Reilly

Best Publications

  • Nutrition and physical activity guidelines for cancer survivors.

    Cheryl L. Rock;Colleen Doyle;Wendy Demark-Wahnefried;Jeffrey A. Meyerhardt

  • Systemic Therapy for Colorectal Cancer

    Jeffrey A. Meyerhardt;Robert J. Mayer

  • Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

    Al B. Benson;Alan P. Venook;Mahmoud M. Al-Hawary;Mustafa A. Arain

  • Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

    Kosuke Mima;Reiko Nishihara;Zhi Rong Qian;Yin Cao

  • Physical Activity and Survival After Colorectal Cancer Diagnosis

    Jeffrey A. Meyerhardt;Edward L. Giovannucci;Michelle D. Holmes;Andrew T. Chan

  • Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.

    Xiaoyun Liao;Paul Lochhead;Reiko Nishihara;Teppei Morikawa

  • Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

    Marios Giannakis;Marios Giannakis;Marios Giannakis;Xinmeng Jasmine Mu;Xinmeng Jasmine Mu;Xinmeng Jasmine Mu;Sachet A. Shukla;Sachet A. Shukla;Zhi Rong Qian

  • NCCN Guidelines® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines

    Al B Benson;Alan P. Venook;Mahmoud M. Al-Hawary;Lynette Cederquist

  • CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

    Shuji Ogino;Katsuhiko Nosho;Gregory J Kirkner;Takako Kawasaki

  • Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803

    Jeffrey A. Meyerhardt;Denise Heseltine;Donna Niedzwiecki;Donna Hollis

  • Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

    Axel Grothey;Alberto F. Sobrero;Anthony F. Shields;Takayuki Yoshino

  • Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

    Alan P. Venook;Donna Niedzwiecki;Heinz Josef Lenz;Federico Innocenti

  • Rectal cancer, version 2.2018 clinical practice guidelines in Oncology

    Al B Benson;Alan P. Venook;Mahmoud M. Al-Hawary;Lynette Cederquist

  • Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer

    Andrew T. Chan;Edward L. Giovannucci;Jeffrey A. Meyerhardt;Eva S. Schernhammer

  • Association of Dietary Patterns With Cancer Recurrence and Survival in Patients With Stage III Colon Cancer

    Jeffrey A. Meyerhardt;Donna Niedzwiecki;Donna Hollis;Leonard B. Saltz

  • Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review†

    Katsuhiko Nosho;Yoshifumi Baba;Noriko Tanaka;Kaori Shima

  • Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

    Andrew X. Zhu;Dushyant V. Sahani;Dan G. Duda;Emmanuelle di Tomaso

  • Impact of diabetes mellitus on outcomes in patients with colon cancer.

    Jeffrey A. Meyerhardt;Paul J. Catalano;Daniel G. Haller;Robert J. Mayer

  • Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.

    Matthew B. Yurgelun;Matthew H. Kulke;Charles S. Fuchs;Brian A. Allen

  • Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication

    Paul Lochhead;Aya Kuchiba;Yu Imamura;Xiaoyun Liao

Frequent Co-Authors

Shuji Ogino
Shuji Ogino Brigham and Women's Hospital
Andrew T. Chan
Andrew T. Chan Harvard University
Kana Wu
Kana Wu Harvard University
Mingyang Song
Mingyang Song Harvard University
Robert J. Mayer
Robert J. Mayer Dana-Farber Cancer Institute
Donna Niedzwiecki
Donna Niedzwiecki Duke University
Reiko Nishihara
Reiko Nishihara Harvard University
Alan P. Venook
Alan P. Venook University of California, San Francisco
Brian M. Wolpin
Brian M. Wolpin Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is just one pathway in the diverse field of healthcare. For students seeking flexibility or alternative roles, a variety of online degrees open doors to impactful careers. For those interested in leadership or hospital management, a bachelors in health administration is a valuable entry point. Graduates can work in hospitals, clinics, and public health organizations.

Advancing further, professionals may want to consider cheapest mha programs online healthcare to gain deeper management expertise and qualify for executive positions. These programs can often be completed part-time and are designed for working professionals.

For nurses aiming for the highest clinical roles, a cheapest dnp prepares graduates for advanced practice and leadership within healthcare systems. Similarly, pharmacists can advance with online pharmacy schools, which offer flexible doctoral programs for those balancing work and study.

These online options increase accessibility, making healthcare careers possible for more students and professionals across the U.S.

Best Scientists Citing Jeffrey A. Meyerhardt

Trending Scientists

Recently Published Articles